Clinical Trial Results:
A phase I/II trial testing nelfinavir, an inhibitor of Akt signaling, in combination with preoperative chemoradiotherapy in patients with locally advanced rectal cancer
Summary
|
|
EudraCT number |
2007-000728-41 |
Trial protocol |
NL |
Global completion date |
22 Apr 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
20 Feb 2020
|
First version publication date |
20 Feb 2020
|
Other versions |
|
Summary report(s) |
J. Buijsen et al. Phase I trial of the combination of the Akt in-hibitor nelfinavir and chemoradiation for locally advanced rectalcancer.Radiotherapy and Oncology 107 (2013) 184–18 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.